Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Schedule Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00968981
What this trial is testing

Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

Who this might be right for
Solid Cancers
Genentech, Inc. 67
Large-scale testing (Phase 3)Study completedNCT00682019
What this trial is testing

Study Evaluation the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction for 10 Weeks

Who this might be right for
Erectile Dysfunction
Bayer 383
Early research (Phase 1)Study completedNCT05205486
What this trial is testing

Pharmacokinetics and Safety of Cefazolin 3gm DUPLEX in Adults

Who this might be right for
Infections
B. Braun Medical Inc. 12
Post-approval studies (Phase 4)WithdrawnNCT03261596
What this trial is testing

Mebendazole Study Against Hookworm Infections in Children and Adolescents in Ghana

Who this might be right for
Hookworm Infections
PATH
Not applicableStudy completedNCT04029454
What this trial is testing

Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule

Who this might be right for
Hepatitis B
Institut Pasteur 10,000
Not applicableStudy completedNCT00410488
What this trial is testing

Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

Who this might be right for
SarcomaNauseaVomiting
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Ended earlyNCT00470249
What this trial is testing

Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University of Southampton 5
Testing effectiveness (Phase 2)Study completedNCT01516749
What this trial is testing

Anakinra as a Treatment for Hydradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
University of California, San Francisco 6
Large-scale testing (Phase 3)Study completedNCT00751348
What this trial is testing

Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136

Who this might be right for
MeaslesVaricellaMumps+1 more
GlaxoSmithKline 475
Not applicableStudy completedNCT00002187
What this trial is testing

ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Ionis Pharmaceuticals, Inc.
Not applicableStudy completedNCT01053104
What this trial is testing

Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring

Who this might be right for
Metastatic Colorectal CancerMetastatic Breast Cancer
University of Oxford 26
Testing effectiveness (Phase 2)Ended earlyNCT00546247
What this trial is testing

Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1)

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 26
Post-approval studies (Phase 4)Study completedNCT01203787
What this trial is testing

Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University of Florida 120
Testing effectiveness (Phase 2)Study completedNCT03970993
What this trial is testing

VAC 072-An Efficacy Study of R21/MM in Different Dose Schedules

Who this might be right for
Malaria
University of Oxford 78
Testing effectiveness (Phase 2)Study completedNCT01537432
What this trial is testing

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Who this might be right for
Psoriasis, Plaque-type Psoriasis
Novartis Pharmaceuticals 36
Post-approval studies (Phase 4)Study completedNCT01037114
What this trial is testing

Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult

Who this might be right for
Hepatitis AHepatitis B
GlaxoSmithKline 50
Large-scale testing (Phase 3)Study completedNCT01429116
What this trial is testing

Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception

Who this might be right for
Non-24-Hour Sleep-Wake Disorder
Vanda Pharmaceuticals 200
Testing effectiveness (Phase 2)Looking for participantsNCT06697184
What this trial is testing

Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Who this might be right for
Chronic Lymphocytic LeukemiaCLLMantle Cell Lymphoma+1 more
BeOne Medicines 258
Testing effectiveness (Phase 2)Ended earlyNCT00387738
What this trial is testing

Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic Adults

Who this might be right for
Rhinitis, Allergic, Seasonal
Dynavax Technologies Corporation 738
Early research (Phase 1)Looking for participantsNCT06911008
What this trial is testing

MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers

Who this might be right for
Metastatic Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
Mayo Clinic 42
Next Page